Deze pagina is verouderd - ontvang onze nieuwtjes per email
Griep vaccins & thimerosal /
thiomersal
Eboek Vaccinatie gevaren (PDF - 271
pagina's)
In de voorafgaande maanden van 2009 heb ik
met het oog op allerlei nogal omstreden vaccinaties de moed gevat om alle tot nu toe
verborgen gebleven gevaren van vaccinaties eens op een rij te zetten en bijeen te brengen
in een samenvattende studie. Hierbij heb ik me gebaseerd op allerlei - verspreide en nooit
in onderlinge samenhang gebrachte - wetenschappelijke publicaties met betrekking tot
allerlei mechanismen die niet alleen gerelateerd zijn aan de gebruikte antigenen, maar die
vooral betrekking hebben op over het hoofd geziene eigenschappen van de gebruikte
hulpstoffen, zoals formaldehyde en verschillende adjuvants, zoals Thimerosal,
aluminiumzouten en MF59 (dat zijn gevaar ontleent aan het bestanddeel Span85).
Er heerst een griepepidemie in Nederland.
Amerikaanse wetenschappers zien een relatie met lage vitamine D waarden. Voedingsbronnen
blijken niet toereikend. Veel mensen hebben een chronisch vitamine D-tekort, zonder het
zelf te weten. Een belangrijke oorzaak is negentig procent van de tijd binnen zitten met
als gevolg een gebrek aan een dagelijkse portie zon (15 tot 30 minuten). Andere oorzaken
zijn: een slechte opname van vitamine D via de darmen, het gebruik van bepaalde
geneesmiddelen of een genetische afwijking. Het bekendste gevolg van een tekort aan
vitamine D3 is botpijn tot zelfs misvormingen aan de beenderen die in extreme gevallen tot
pijnlijke, spontane breuken kan leiden. Aavulling van vitamine D zorgt tot op hoge
leeftijd voor een stevig en pijnvrij beenderstelsel.
Ik kan het niet vaak genoeg zeggen,
vitamine D is zoveel meer belangrijker dan griepvaccins. Je D niveau is nu op een
dieptepunt door gebrek aan zonlicht. Ik neem zelf 4000IE per dag om dit tekort te
verhelpen. Ik heb deze winter geen verkoudheid, keelontsteking of griep gehad. Bot- en
spierpijnen hebben ook met D tekort te maken. D regelt ook de opname van calcium voor je
botten. Wat doen we in Nederland? Juist, absurd hoge inname van calcium en dan geen D
erbij. Kalk gaat dus zwerven ipv richting de botten. Magnesium is ook zo belangrijk voor
je botten en laat nu juist zuivel niets bevatten. Calcium en magnesium zitten samen in
groene groente en noten. Geloof die melkpropaganda niet, hele volken hebben sterke botten
door voldoende D en het eten van noten/groente. Focus dus op voeding die zowel calcium als
magnesium bevat en zorg voor vitamine D, bij gebrek aan zonlicht dus suppletie van D3 !!
Het gaat altijd om een balans van stoffen, niet overdosering van 1 mineraal, dat werkt
juist averrechts. Recent weer studie naar aggressieve prostaatkanker, de patiënten bleken
hoge calciumwaardes in hun bloed te hebben.
Ron
Just How Effective is the Flu
Vaccine? - CBN.com
We hear more and more about the flu
vaccine. But is it worth the shot in the arm? Or is it a shot in the dark?
Opnieuw bewijs dat voordelen
griepvaccins zwaar overdreven zijn en de kans op overlijden niet verkleinen
Flu shot does not reduce risk of
death !!
The widely-held perception that the
influenza vaccination reduces overall mortality risk in the elderly does not withstand
careful scrutiny, according to researchers in Alberta. The vaccine does confer protection
against specific strains of influenza, but its overall benefit appears to have been
exaggerated by a number of observational studies that found a very large reduction in
all-cause mortality among elderly patients who had been vaccinated. The results will
appear in the first issue for September of the American Journal of Respiratory and
Critical Care Medicine, a publication of the American Thoracic Society. The study included
more than 700 matched elderly subjects, half of whom had taken the vaccine and half of
whom had not. After controlling for a wealth of variables that were largely not considered
or simply not available in previous studies that reported the mortality benefit, the
researchers concluded that any such benefit "if present at all, was very small and
statistically non-significant and may simply be a healthy-user artifact that they were
unable to identify." "While such a reduction in all-cause mortality would have
been impressive, these mortality benefits are likely implausible. Previous studies were
likely measuring a benefit not directly attributable to the vaccine itself, but something
specific to the individuals who were vaccinated—a healthy-user benefit or frailty
bias," said Dean T. Eurich,Ph.D. clinical epidemiologist and assistant professor at
the School of Public Health at the University of Alberta. "Over the last two decades
in the United Sates, even while vaccination rates among the elderly have increased from 15
to 65 percent, there has been no commensurate decrease in hospital admissions or all-cause
mortality. Further, only about 10 percent of winter-time deaths in the United States are
attributable to influenza, thus to suggest that the vaccine can reduce 50 percent of
deaths from all causes is implausible in our opinion." Dr. Eurich and colleagues
hypothesized that if the healthy-user effect was responsible for the mortality benefit
associated with influenza vaccination seen in observational studies, there should also be
a significant mortality benefit present during the "off-season". To determine
whether the observed mortality benefits were actually an effect of the flu vaccine,
therefore, they analyzed clinical data from records of all six hospitals in the Capital
Health region in Alberta. In total, they analyzed data from 704 patients 65 years of age
and older who were admitted to the hospital for community-acquired pneumonia during
non-flu season, half of whom had been vaccinated, and half of whom had not. Each
vaccinated patient was matched to a non-vaccinated patient with similar demographics,
medical conditions, functional status, smoking status and current prescription
medications. In examining in-hospital mortality, they found that 12 percent of the
patients died overall, with a median length of stay of approximately eight days. While
analysis with a model similar to that employed by past observational studies indeed showed
that patients who were vaccinated were about half as likely to die as unvaccinated
patients, a finding consistent with other studies, they found a striking difference after
adjusting for detailed clinical information, such as the need for an advanced directive,
pneumococcal immunizations, socioeconomic status, as well as sex, smoking, functional
status and severity of disease. Controlling for those variables reduced the relative risk
of death to a statistically non-significant 19 percent. Further analyses that included
more than 3,400 patients from the same cohort did not significantly alter the relative
risk. The researchers concluded that there was a difficult to capture healthy-user effect
among vaccinated patients. "The healthy-user effect is seen in what doctors often
refer to as their 'good' patients— patients who are well-informed about their health,
who exercise regularly, do not smoke or have quit, drink only in moderation, watch what
they eat, come in regularly for health maintenance visits and disease screenings, take
their medications exactly as prescribed— and quite religiously get vaccinated each
year so as to stay healthy. Such attributes are almost impossible to capture in large
scale studies using administrative databases," said principal investigator Sumit
Majumdar, M.D., M.P.H., associate professor in the Faculty of Medicine & Dentistry at
the University of Alberta.
NJ Flu Shots Fox & Friends Live
Segment
Louise Kuo Habakus and Claudine Liss
discuss mandatory flu shots and vaccination choice.
Vaccinaties en griep
Alvorens de geschiedenis van het
reislustige griepvirus en het ontstaan van griep als gevolg van menselijk handelen aan u
voor te leggen, wil ik u eerst kenbaar maken dat u datgene wat hieronder in de kantlijn
staat eigenlijk had moeten weten vooraleer u een besluit neemt om een griepvaccinatie of
een vaccinatie in zijn algemeenheid te nemen.
Bedenk voor u gaat of laat vaccineren:
*teveel vaccinaties in een korte periode
zijn gevaarlijk
*vaccins zijn eigenlijk vergiften
*denk tweemaal na voor u een griepinjectie neemt
*bij een slecht werkend immuunsysteem is het oppassen met vaccinaties
*onderzoek heeft uitgewezen dat griepinjecties Alzheimer kunnen veroorzaken
*winsten, en niet de noodzaak, hebben van vaccins een modeverschijnsel gemaakt
Wat medisch en wetenschappelijk algemeen
bekend is en wat U eigenlijk had moeten weten:
De meeste wetenschappers en medici hebben
natuurlijk gehoord van de discussies over mogelijke schadelijke effecten van sommige
vaccins. En ze weten drommels goed dat het veroorzaken van ziekten door medisch handelen,
de zogenaamde iatrogene ziekten, bij het grote publiek zo goed als onbekend is en dat de
outsider, de leek dus, van alles wijs gemaakt kan worden. Echt alarmerende berichten
worden voor het grootste deel verborgen in technisch-wetenschappelijke tijdschriften of
afgedekt door de medische- en farmaceutische maffia waardoor de echte waarheid buiten het
bereik van het gewone publiek blijft. Door wie bijvoorbeeld werd Yomanda bijvoorbeeld aan
de schandpaal genageld? Of de alternatieve beroepsgroep die voor kwakzalvers worden
uitgemaakt? Bovendien zijn 'de deskundigen' in de gezondheidszorg bang dat hun machtige
schip op de klippen zal varen als het publiek kennis krijgt van de werkelijke gevaren die
aan vaccinaties verbonden zijn.
Op diverse pagina’s wordt Dr. Hugh
Fudenburg geciteerd, die na uitgebreid onderzoek van gegevens over 1970 tot 1980 zei:
‘Als een individu tussen 1970 en 1980 vijf keer na elkaar een griepprik heeft
gehad, dan is de kans dat die persoon Alzheimer krijgt 10 maal groter dan wanneer
diezelfde persoon 2 of minder griepprikken heeft gehad.’ Fudenburg was een zeer
vooraanstaand arts en onderzoeker in de immunogenetica die o.a. voor de World Health
Organization gewerkt heeft, en zeer veel wetenschappelijk publicaties op zijn naam heeft
staan. In 1995 werd hij uit zijn ambt gezet vanwege ‘onethisch en onprofessioneel
gedrag’, een lot wat veel klokkenluiders in de medische hoek beschoren is. Als u
liever gelooft dat Fudenburg een kwakzalver is: ‘be my guest’.
Kwakzalver of expert? , oordeel zelf, een
stukje van zijn CV
Career Highlights H. Hugh Fudenberg, MD
The Chief Editor of the journal Clinical
Immunology and Immunopathology for 15 years and at one time or another has been on the
editorial boards of 35 other journals dealing with immunology, aging, hematology, cancer,
toxicology, etc.
The first in this country to develop
methods for measuring levels of immune antibody globulins (IgG, IgA, IgM).
Developed the technique for therapeutic
plasmapheresis (separation of plasma and red blood cells) to remove harmful antibodies
(e.g., in Myasthenia Gravis, Guillain-Barre Syndrome, etc.), which led to the development
of the cell separator which is now used to obtain preparations of pure immune cells.
The first to measure genetic factors on
antibody molecules (Gm factors) and was the first to show that these are linked to
weakness or resistance to different diseases (e.g., pneumococcal pneumonia, meningococcal
meningitis, etc).
Disproved two hypotheses for which the
proponents had won the Nobel Prize: (1) that a single gene determined a given polypeptide
chain; he showed that for immunoglobulins multiple genes (over 200) determine each
polypeptide chain; (2) that the DNA to RNA to Protein sequence was a universal phenomenon;
he showed the order in immune sequence to be Protein-RNA-DNA. (These findings were
presented at a Nobel Prize Symposium in Sweden in 1967).
The first to use Dialyzable Leukocyte (and
later Lymphocyte) Extract (DLE) containing Transfer Factor (TF) therapeutically and to
demonstrate its efficacy in hitherto untreatable diseases such as some forms of
immunodeficiency (e.g., congenital absence of the thymus and various viral, parasitic,
mycobacterial {leprosy}, and fungal diseases {systemic candidiasis} and against cancer
metastasis). He has also proven TF's therapeutic value in Chronic Fatigue - Immune
Dysregulation Syndrome (CFIDS), subsets of Autism and Alzheimer's Disease, etc., in
primary osteosarcoma in man and in an animal model. Published double-blind studies have
proven the efficacy of antigen-specific Transfer Factors (a different one for each
disease).
Developed the Rosette tests which labs use
today as screening tests for immune capability.
Discovered that cell-mediated immunity
(CMI), not humoral immunity (i.e., antibodies) to be deficient in certain disorders of
cognitive function. (e.g., Alzheimer's disease, Autism, CFIDS, etc.)
In 1984, predicted the failure of proposed
HIV (AIDS) vaccines because they induced antibodies, whereas his data suggested the virus
caused a defect in CMI.
Holds four honorary professorships (from
universities in France, Italy, China, and Finland).
Discovered the Suppressor T-cell (1964) and
showed that low levels thereof predispose an individual to auto-immune diseases such as
lupus, lymphoma, etc. (in man and mice).
Has given 35 different Annual Medal
Lectures (e.g., Hungarian Society of Immunology, Danish Cancer Society, Petrov Medal of
the Russian Cancer Society, British Society of Immunology, American Academy of Allergy,
etc.) throughout the world on his findings and has been visiting professor at every
leading medical school in this country and abroad (Harvard, Yale, Columbia, Princeton,
Oxford and Cambridge {England}, University of Barcelona {Spain}, University of Beijing
{China}; every medical school in Italy, South Africa and Turkey; and selected medical
schools in South America, etc.) as well as at prominent Research Institutes (e.g.,
Sloan-Kettering, M.D. Anderson, Karolinska Institute {Sweden}, Pasteur Institute {France},
and others in the U.S. and abroad).
Author or co-author of 800+ scientific
articles, many published in the world's most highly-respected journals (such as: Lancet,
Science, New England Journal of Medicine, Journal of Clinical Investigation, and
Proceedings of the National Academy of Sciences), and in over 20 immunology journals
(e.g., Scandinavian Journal of Immunology).
Chief author of Basic and Clinical
Immunology, the most widely-used immunology text in the world, translated into 12
languages, and of Basic Immunogenetics, the standard text in this sub-specialty of
immunology, translated into Russian, Chinese, and four other languages.
In 1985 showed that there were at least two
types of monocytes, one helper and one suppressor, and further showed that the ratio of
suppressor monocytes to helper monocytes was greatly increased in the cord blood of
infants, suppressing the response of maternal immune cells and explaining why the mother's
immune system never rejects the fetus.
The first to show that Alzheimer's Disease
contains at least 4 subsets and has devised therapy for two of the 4 types.
The first to show that there are at least 8
different disorders within the Autistic spectrum, and has devised therapy for 3 of these;
in some cases patients have been restored to normal childhood development, i.e.,
mainstreamed.
Showed that Chronic Immune Dysregulation
Syndrome (CFIDS), also known as Florence Nightingale Disease, is caused by different
viruses in different patients, and has successfully treated 85% of such patients seen.
In 1982, showed that the dopamine receptor
(neuronal receptor with greatest affinity for dopamine as compared to all other agents)
was in reality the D2 receptor. What had up to then been called the D1 receptor had a
greater affinity for PCP, "angel dust," thus accounting for permanent
schizophrenia-like symptoms in individuals in whom this disorder lasted for at least 6
months. Aggregation of PCP by slight heat (e.g., 38oC) caused even greater binding to the
D1 receptor. Apparently individuals who took PCP and recovered in several days differed
from those whose defects were life long had had mild viral infection at time of exposure
to PCP.
Has served on four Expert Committees of the
World Health Organization, including 20 years on the Expert Advisory Panel on Immunology.
Has trained over 150 individuals who either
received a Ph.D. or Post Doctorate training (M.D.'s and/or Ph.D.'s). Nearly all are active
in research, though many are department chairmen which reduces research time. These
include Professors of Immunology, Microbiology, Pediatrics, Medicine, Dermatology,
Ophthalmology, Anesthesiology, Pathology, Laboratory Medicine, Surgery, Veterinary
Medicine, etc., as well as section heads at prestigious biotech firms. (Of 11 exceptions
to the above, 1 is a university president, 2 are university vice-presidents, 4 are deans,
4 are in clinical practice.)
The first to use antigen specific
immunoglobulin human transfer factor clinically to treat many supposedly untreatable
conditions and to cure supposedly incurable diseases.
Expert on illness due to toxic effects of
microbiological agents, herbacides, heavy metals, etc. that cause memory problems,
especially those related to auditory memory.
Developed effective therapies for ADD,
AIDS, Autism, Alzheimer's, CFIDS, HIV, MS and others.
En dat noemen andere wetenschappers dus een
kwakzalver
Ron
Do Flu Shots Work? Ask A Vaccine
Manufacturer
Two years ago a study in the British
Medical Journal concluded that the effectiveness of annual flu shots has been exaggerated,
and that in reality they have little or no effect on influenza campaign objectives,
including reducing the number of hospital stays, time off work, and death from influenza
and its complications. Other studies, done prior and subsequently, also confirm these
findings. However, preventing flu-related deaths in the elderly has been, and still is,
the primary argument for recommending flu shots each year. And, according to the theory of
“herd immunity,” a majority of the population must be vaccinated in order to
protect the lives of the elderly and other categories of people susceptible to flu-related
complications. However, the flu prevention strategy set by the Centers for Disease Control
and Prevention (CDC) has been called into serious question time and again.
Griepvaccin biedt toch minder
bescherming dan gedacht
A Group Health study in the Aug. 2 Lancet
fuels the growing controversy over how well the flu vaccine protects seniors. The study of
more than 3,500 Group Health patients age 65 found no link between flu vaccination and
risk of pneumonia during three flu seasons. This largest case-control study of flu vaccine
in the elderly suggests the flu vaccine doesn't protect seniors as much as has been
thought.
Nederlandse en Amerikaanse wetenschappers
zijn het oneens over het effect van de jaarlijkse injectie bij bejaarden. Ouderen
vaccineren tegen wintergriep helpt, klonk het donderdag vanuit Maastricht. Amerikaanse
epidemiologen denken daar anders over. Het griepvaccin, schrijven ze in The Lancet,
beschermt oude mensen niet tegen longontsteking. Het is een nieuw hoofdstuk in een ruzie
onder vaccin-experts over het nut van de griepprik. Miljoenen Nederlanders krijgen die
jaarlijks. De discussie begon donderdag met een persbericht van de Universiteit
Maastricht.
Meer twijfels over de
effectiviteit en veiligheid van het griepvaccin
Volgens epidemiloog Dr Tom
Jefferson heeft het zogenaamde inactieve griepvaccin voor ouderen weinig zin. Hij bekeek
de studies die er reeds zijn gedaan naar bijvoorbeeld bezoek aan ziekenhuizen, afwezigheid
op het werk, dood of complicaties door griep en zag dat het weinig effect had. Ook
tonen de studies weinig bewijs van de veiligheid van de vaccins. Ook Dr Jefferson van het
onafhankelijke Cochrane instituut die studies controleert spreekt van weinig tot geen
effect en noemt ook de slechte kwaliteit van de gedane studies. http://www.lse.co.uk/ShowStory.asp?story=WR2630459N
No Evidence Flu Jabs Work for
Under-2s - Study. There is no evidence that vaccinating children under 2 years old against
influenza reduces deaths or complications from the illness, researchers said on Friday.
They reviewed 25 studies that looked at the impact of vaccines in cutting the
number of cases of influenza and its symptoms in children up to 16. "Immunization of
very young children is not lent support by our findings," said Dr Tom Jefferson, of
the Cochrane Vaccines Field in Rome, part of the international Cochrane Collaboration that
evaluates medical research. "We recorded no convincing evidence that vaccines can
reduce mortality, admissions, serious complications and community transmission of
influenza," he added in a report in The Lancet medical journal. http://www.askdrsears.com/news/headlines0205.asp
Video - Eye On The Flu Shot
the ingredients poisoning your children
Voordelen van griepvaccins erg
overdreven
Mortality benefits of influenza
vaccination in elderly people: an ongoing controversy
Influenza vaccination policy in most
high-income countries attempts to reduce the mortality burden of influenza by targeting
people aged at least 65 years for vaccination. However, the effectiveness of this strategy
is under debate. Although placebo-controlled randomised trials show influenza vaccine is
effective in younger adults, few trials have included elderly people, and especially those
aged at least 70 years, the age-group that accounts for three-quarters of all
influenza-related deaths. Recent excess mortality studies were unable to confirm a decline
in influenza-related mortality since 1980, even as vaccination coverage increased from 15%
to 65%. Paradoxically, whereas those studies attribute about 5% of all winter deaths to
influenza, many cohort studies report a 50% reduction in the total risk of death in
winter—a benefit ten times greater than the estimated influenza mortality burden. New
studies, however, have shown substantial unadjusted selection bias in previous cohort
studies. We propose an analytical framework for detecting such residual bias. We conclude
that frailty selection bias and use of non-specific endpoints such as all-cause mortality
have led cohort studies to greatly exaggerate vaccine benefits. The
remaining evidence base is currently insufficient to indicate the magnitude of the
mortality benefit, if any, that elderly people derive from the vaccination programme.
Nieuw immunotoxisch effect
Thimerosal (zit in vele griepvaccins) verandert werking van dendrietcellen
Thimerosal, een conserveermiddel op basis
van kwik, dat oa in de meerderheid van griepvaccins wordt gebruikt is al eerder gelinkt
aan neurotoxische effecten. Nieuw onderzoek onthult nu ook het effect op het immuunsysteem
doordat het de manier waarop dendrietcellen reageren op biochemische signalen verandert.
Deze cellen spelen een belangrijke rol bij infecties. Eén geactiveerde dendriet cel kan
al honderden T-cellen op de indringer afsturen, maar dan moet de cel dus wel goed
reageren.
Bij concentraties van 200 ppb gingen deze
dendriet cellen zelfs dood!. Het doorlopende gebruik van thimerosal in (griep)vaccins en
andere produkten moet dus reden zijn voor meer onderzoek naar deze immuuntoxische effect
van dit middel en het aandeel ethylkwik daarbij.
Meer dan 1 miljoen kinderen
krijgen nog steeds kwik vaccins:
de griepprik !
The Age of Autism: Mercury creeps back in
New calculations suggest children today
can be exposed to more than half the mercury that was in vaccines in the 1990s, even
though manufacturers began phasing it out in 1999. Adjusted for a child's body weight at
the time of the shots, there's virtually no reduction at all, according to this analysis.
The source: Flu vaccines, which have been
recommended for millions more kids over 6 months old and pregnant women in the past few
years. Most of those shots still contain the mercury-based preservative called thimerosal
that some fear is behind a huge rise in autism diagnoses. "It's been under the radar
and it's allowed health officials to say, 'We've taken it out of all the childhood
vaccines,'" said Dr. David Ayoub, an Illinois anti-thimerosal activist who put the
data together along with Maryland researchers David Geier and Dr. Mark Geier. "They
don't consider influenza one of the mandated childhood vaccines yet," Ayoub said. But
because the Centers for Disease Control and Prevention now recommends flu shots for all
pregnant women and all children between 6 months and age 5, doctors routinely give them.
Missing the Flu Diagnosis in Kids
Just Another Excuse for a Vaccine
Flu infections in young children are
often missed by doctors, a new study reports. The diagnosis was missed in four out of five
preschoolers treated for flu symptoms at a doctor's office or emergency room, and in about
three-quarters of those who were hospitalized. During the four-year study, the researchers
conducted their own lab tests on children who saw doctors for symptoms such as cough,
runny nose
and fever. Only 28 percent of hospitalized flu cases and 17 percent of those who visited a
doctor or emergency room were diagnosed with the flu. Other diagnoses included asthma,
pneumonia and general viral illness.
The researchers, two of which received
grant support and consulting fees from MedImmune Inc., the maker of a spray flu vaccine,
said using a rapid flu test more often could detect more cases of flu and help prevent its
spread. Further, one-third of the children could have taken a drug like
Tamiflu to ease their symptoms.
The results were presented to a Centers
for Disease Control and Prevention (CDC) panel, which recommended expanding 2006 flu shots
for children between the ages of 2 and 5; flu shots are already recommended for children
aged 6-23 months.
